SA
IBO

S&P 500, Nasdaq, Russell 2000 below the 200-day average · VIX 35.9 · very high volatility

Overview →

Impact BioMedical Inc. is a biotechnology firm focused on developing innovative therapies for various diseases, leveraging proprietary technologies in regenerative medicine. The company operates primarily in the U.S. market and is distinguished by its unique approach to bioengineering and its partnerships with academic institutions for research and development.

HealthcareBiotechnologylow - The company has high fixed costs associated with R&D and limited revenue streams, resulting in low operating leverage.

Business Overview

01Research grants and collaborations with academic institutions (estimated 60%)
02Licensing of proprietary technologies (estimated 30%)
03Consulting services in biotechnology (estimated 10%)

Impact BioMedical generates revenue through a combination of research grants, technology licensing, and consulting services. Its competitive advantage lies in its proprietary bioengineering technologies and strong academic partnerships, which provide access to cutting-edge research and innovation.

What Moves the Stock

Success in clinical trials for new therapies

Partnership announcements with major pharmaceutical companies

Regulatory approvals for new drug applications

Changes in funding availability for biotechnology research

Watch on Earnings
Clinical trial progress updatesRevenue from licensing agreementsR&D expenditure as a percentage of revenue

Risk Factors

Regulatory changes affecting drug approval processes

Technological disruption from emerging biotech firms

Increased competition from larger pharmaceutical companies with more resources

Potential for rapid advancements in alternative therapies

Liquidity risk due to negative cash flow and reliance on external funding

Vulnerability to changes in grant funding availability

StructuralCompetitiveBalance Sheet

Macro Sensitivity

Economic Cycle

moderate - The biotechnology sector is somewhat insulated from economic downturns but can be affected by changes in healthcare spending and funding for research.

Interest Rates

Interest rates impact the company's ability to finance R&D projects and may affect the valuation of future cash flows, particularly in a high-interest environment.

Credit

minimal - The company has no debt, reducing its exposure to credit market fluctuations.

Live Conditions
S&P 500 FuturesRussell 2000 FuturesDow Jones Futures

Profile

growth - Investors seeking high-risk, high-reward opportunities in the biotech sector.

high - The stock has historically exhibited high volatility due to the binary nature of clinical trial outcomes.

Key Metrics to Watch
Clinical trial success rates
Number of active research collaborations
Revenue growth from licensing agreements
R&D expenditure trends
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.